Elevated tissue factor and VEGF, markers of endothelial injury, drive coagulation in HLH independent of platelet counts—a phenomenon necessitating vigilance even in thrombocytopenic patients [31]. This evidence concerns the gene VEGFA and hemophagocytic syndrome.